Resultados de la búsqueda 21-30 of 1459 for 云主机 1元,vps 100m独享,vps线路延迟,518vps挂机宝官网,vps怎么登,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wg.gs

  1. Neurología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to understand how electrical stimulation of the brain can modulate and suppress interictal epileptiform activity as a step on the ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the clinical outcomes of the Micropulse Trans-Scleral Cyclophotocoagulation Laser (MPTSCPC) after 1 day, 1 week,1 ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    Metastatic Tumor Research and Outcomes Network ... Rochester, Minn. The registry aims to collect patient information such as patient demographics, co-morbidities, ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to follow Mayo Clinic patients with severe brachial plexus injuries who underwent upper limb amputation.

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    ... 1) or to primary colorectal carcinoma (Arm 2), based on treatment-related adverse events reported by National Cancer Institute (NCI) Common Terminology ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    Pre-operative Vs. Post-operative Radiosurgery For Metastatic Brain Tumors. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this ...

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

  10. Neurología - Ensayos clínicos - Mayo Clinic

    ... (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in ...